Ontology highlight
ABSTRACT: Introduction
Pharmacogenetic testing may assist in identifying an individual's risk of developing a mental illness as well as predict an individual's response to treatment. The objective of this study is to report published outcomes of pharmacogenetic testing in patients with schizophrenia or bipolar disorder.Methods
A systematic review using PubMed and EBSCOhost through April 2017 was performed to identify articles that reported pharmacogenetic testing in adult patients with either bipolar disorder or schizophrenia using the keywords pharmacy, pharmacogenomics, pharmacogenetics, psychiatry, bipolar disorder, schizophrenia, mood stabilizer, and antipsychotic.Results
A total of 18 articles were included in the f
SUBMITTER: Routhieaux M
PROVIDER: S-EPMC6213894 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature